Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
21.83
-0.82 (-3.62%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pulse Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -72.78 | -53.59 | -42.21 | -58.51 | -63.66 | Upgrade
|
| Depreciation & Amortization | 1.07 | 1.18 | 1.21 | 1.36 | 1.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.01 | 0.01 | 0.19 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.01 | Upgrade
|
| Stock-Based Compensation | 21.46 | 13.59 | 7.18 | 5.19 | 14.6 | Upgrade
|
| Other Operating Activities | 1.15 | 0.92 | - | 8.48 | - | Upgrade
|
| Change in Accounts Receivable | -0.27 | - | - | 0.06 | -0.06 | Upgrade
|
| Change in Inventory | -0.14 | - | - | -2.65 | -5.82 | Upgrade
|
| Change in Accounts Payable | 1.13 | -0.2 | 0.26 | -1.3 | 1.16 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.02 | 0.02 | Upgrade
|
| Change in Other Net Operating Assets | -5.74 | 1.75 | 0.51 | 0.2 | -1.49 | Upgrade
|
| Operating Cash Flow | -54.12 | -36.34 | -33.04 | -47.01 | -54.1 | Upgrade
|
| Capital Expenditures | -0.32 | -0.13 | -0.12 | -0.4 | -0.44 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.02 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | 8 | Upgrade
|
| Investing Cash Flow | -0.34 | -0.13 | -0.12 | -0.4 | 7.56 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1.94 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 65 | - | Upgrade
|
| Total Debt Issued | - | - | - | 65 | 1.94 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.44 | -1.53 | Upgrade
|
| Total Debt Repaid | - | - | - | -0.44 | -1.53 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 64.56 | 0.41 | Upgrade
|
| Issuance of Common Stock | 17.15 | 110.42 | 16.39 | 15.38 | 62.51 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.23 | Upgrade
|
| Other Financing Activities | - | -0.28 | -0.01 | - | - | Upgrade
|
| Financing Cash Flow | 17.15 | 110.14 | 16.39 | 79.94 | 62.69 | Upgrade
|
| Net Cash Flow | -37.3 | 73.67 | -16.77 | 32.53 | 16.15 | Upgrade
|
| Free Cash Flow | -54.44 | -36.47 | -33.16 | -47.41 | -54.53 | Upgrade
|
| Free Cash Flow Margin | -15553.43% | - | - | -6773.43% | -3845.84% | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -0.62 | -0.67 | -1.40 | -1.95 | Upgrade
|
| Cash Interest Paid | - | - | 1.7 | - | - | Upgrade
|
| Levered Free Cash Flow | -29.52 | -17.92 | -18.13 | -26.84 | -30.4 | Upgrade
|
| Unlevered Free Cash Flow | -29.52 | -17.92 | -17.44 | -26.27 | -29.96 | Upgrade
|
| Change in Working Capital | -5.02 | 1.55 | 0.77 | -3.72 | -6.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.